Boosting trust in AI: The essential foundation for breakthro...
The use of artificial intelligence (AI) in healthcare is growing rapidly and already providing patients with better care and support.
When costing and compliance collide
Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
Madrigal closes on EU approval of first MASH treatment
Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
EVERSANA expands commercialisation portfolio with OS Therapi...
EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic partnerships to support the US commercialisation of innovative therapies from O
The Pharmaceutical Marketing Society and the Chartered Insti...
The PM Society is delighted to announce a new partnership with the CIM to build capability and excellence in marketing in the pharmaceutical industry.
15th World Clinical Biomarkers & Companion Diagnostics Summi...
The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
5th iPSC Drug Development Summit
Advance iPSC therapies from bench to bedside with 30+ industry experts at this year’s summit.